BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20586999)

  • 1. Incontinentia pigmenti revisited. A novel nonsense mutation of the IKBKG gene.
    Fryssira H; Kakourou T; Valari M; Stefanaki K; Amenta S; Kanavakis E
    Acta Paediatr; 2011 Jan; 100(1):128-33. PubMed ID: 20586999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incontinentia pigmenti in a newborn with a novel nonsense mutation in the NEMO gene.
    Has C; Danescu S; Volz A; Nöh F; Technau K; Bruckner-Tuderman L
    Br J Dermatol; 2007 Feb; 156(2):392-3. PubMed ID: 17223894
    [No Abstract]   [Full Text] [Related]  

  • 3. Incontinentia pigmenti in a Japanese female infant with a novel frame-shift mutation in the IKBKG gene.
    Li M; Higashi N; Nakano H; Saeki H
    J Dermatol; 2019 Jan; 46(1):e26-e28. PubMed ID: 29923632
    [No Abstract]   [Full Text] [Related]  

  • 4. A Novel Frameshift Mutation of the IKBKG Gene Causing Typical Incontinentia Pigmenti.
    Minić S; Trpinac D; Obradović M
    Srp Arh Celok Lek; 2015; 143(11-12):752-4. PubMed ID: 26946775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel IKBKG mutation in a patient with incontinentia pigmenti and features of hepatic ciliopathy.
    Danescu S; Has C; Baican C; Müller T; Baican A
    Australas J Dermatol; 2018 Nov; 59(4):e262-e265. PubMed ID: 29520766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.
    Conte MI; Pescatore A; Paciolla M; Esposito E; Miano MG; Lioi MB; McAleer MA; Giardino G; Pignata C; Irvine AD; Scheuerle AE; Royer G; Hadj-Rabia S; Bodemer C; Bonnefont JP; Munnich A; Smahi A; Steffann J; Fusco F; Ursini MV
    Hum Mutat; 2014 Feb; 35(2):165-77. PubMed ID: 24339369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incontinentia pigmenti diagnostic criteria update.
    Minić S; Trpinac D; Obradović M
    Clin Genet; 2014 Jun; 85(6):536-42. PubMed ID: 23802866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients.
    Zou CC; Zhao ZY
    Int J Dermatol; 2007 Oct; 46(10):1017-22. PubMed ID: 17910706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histologic features of incontinentia pigmenti in adults with nuclear factor-κB essential modulator gene mutations.
    Hadj-Rabia S; Rimella A; Smahi A; Fraitag S; Hamel-Teillac D; Bonnefont JP; de Prost Y; Bodemer C
    J Am Acad Dermatol; 2011 Mar; 64(3):508-15. PubMed ID: 21255870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proposal for a protocol for the staging of incontinentia pigmenti in pediatric age].
    Portaleone D; Taroni F; Micheli S; Moioli M; Pedrazzini A; Cognizzoli P; Carnelli V
    Minerva Pediatr; 2007 Jun; 59(3):255-65. PubMed ID: 17519871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomorphic mutation of IKBKG in a male patient with incontinentia pigmenti.
    Niki M; Hirose K; Matsudate Y
    J Dermatol; 2020 Apr; 47(4):e113-e114. PubMed ID: 31984548
    [No Abstract]   [Full Text] [Related]  

  • 12. A rare cause of neonatal seizure: incontinentia pigmenti.
    Türkmen M; Eliaçik K; Temoçin K; Savk E; Tosun A; Dikicioğlu E
    Turk J Pediatr; 2007; 49(3):327-30. PubMed ID: 17990592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mosaicism of a novel IKBKG mutation in a male patient with incontinentia pigmenti.
    Hull S; Arno G; Thomson P; Mutch S; Webster AR; Rai H; Hill V; Moore AT
    Am J Med Genet A; 2015 Jul; 167(7):1601-4. PubMed ID: 25944529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal white matter in a neurologically intact child with incontinentia pigmenti.
    Bryant SA; Rutledge SL
    Pediatr Neurol; 2007 Mar; 36(3):199-201. PubMed ID: 17352958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic cause for neonatal encephalopathy: incontinentia pigmenti with NEMO mutation.
    Loh NR; Jadresic LP; Whitelaw A
    Acta Paediatr; 2008 Mar; 97(3):379-81. PubMed ID: 18241293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incontinentia pigmenti with ultrastructurally disordered leucocytes.
    Minić S; Trpinac D; Obradović M; Novotny GE; Gabriel HD; Kuhn M
    J Clin Pathol; 2010 Jul; 63(7):657-9. PubMed ID: 20591917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel inhibitor of nuclear factor kappa-B kinase subunit gamma mutation identified in an incontinentia pigmenti patient with syndromic tooth agenesis.
    Sun S; Li F; Liu Y; Qu H; Wong SW; Zeng L; Yu M; Feng H; Liu H; Han D
    Arch Oral Biol; 2019 May; 101():100-107. PubMed ID: 30913450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose glucocorticoid therapy in the management of seizures in neonatal incontinentia pigmenti: a case report.
    Wolf DS; Golden WC; Hoover-Fong J; Applegate C; Cohen BA; Germain-Lee EL; Goldberg MF; Crawford TO; Gauda EB
    J Child Neurol; 2015 Jan; 30(1):100-6. PubMed ID: 24682289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin ulcer mimicking pyoderma gangrenosum in a patient with incontinentia pigmenti.
    Yoshida M; Oiso N; Kimura M; Itoh T; Kawada A
    J Dermatol; 2011 Oct; 38(10):1019-21. PubMed ID: 21972955
    [No Abstract]   [Full Text] [Related]  

  • 20. Destructive encephalopathy in incontinentia pigmenti.
    Hart AR; Edwards C; Mahajan J; Wood ML; Griffiths PD
    Dev Med Child Neurol; 2009 Feb; 51(2):162-3. PubMed ID: 19055595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.